Carcinoembryonic antigen as a target for cancer vaccines

Cancer Immunology Immunotherapy

Volumn 43, Issue 3, 1996, Pages 127-134

  Hodge, James W ^a   Schlom, J ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

anti idiotype; cancer vaccines; carcinoembryonic antigen; immunotherapy; polynucleotide immunization; recombinant poxviruses

Indexed keywords

CANCER VACCINE; CARCINOEMBRYONIC ANTIGEN; CYTOKINE; IDIOTYPIC ANTIBODY;

CANCER IMMUNOTHERAPY; CONFERENCE PAPER; HUMAN; IMMUNOGLOBULIN GENE; PRIORITY JOURNAL; T LYMPHOCYTE;

ANIMALS; ANTIBODIES, ANTI-IDIOTYPIC; CANCER VACCINES; CARCINOEMBRYONIC ANTIGEN; CLINICAL TRIALS, PHASE I; HUMANS; IMMUNIZATION; MICE; NEOPLASM PROTEINS; NEOPLASMS; TRANSFECTION; VACCINES, SYNTHETIC; VACCINIA VIRUS;

EID: 0029949563     PISSN: 03407004     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002620050313     Document Type: Conference Paper

References (38)

1. Ansardi DC, Moldoveanu Z, Porter DC, Walker DE, Conry RM, LoBuglio AF, McPherson S, Marrow CD (1994) Characterization of poliovirus replicons encoding carcinoembryonic antigen. Cancer Res 54: 6359
2. Beauchemin N, Benchimol S, Cournoyer D, Fuks A, Stanners CP (1987) Isolation and characterization of full-length functional cDNA clones for human carcinoembryonic antigen. Mol Cell Biol 7: 3221
3. Bei R, Kantor J, Kashmiri SV, Abrams S, Schlom J (1994) Enhanced immune responses and anti-tumor activity by baculovirus recombinant carcinoembryonic antigen (CEA) in mice primed with the recombinant vaccinia CEA. J Immunother Emphasis Tumor Immunol 16: 275
4. Bei R, Kantor J, Kashmiri SV, Schlom J (1994) Serological and biochemical characterization of recombinant baculovirus carcinoembryonic antigen. Mol Immunol 31: 771
5. Bhattachary-Chatterjee M, Mukerjee S, Biddle W, Foon KA, Kohler H (1990) Murine monoclonal anti-idiotype antibody as a potential network antigen for human carcinoembryonic antigen. J Immunol 145: 2758
6. Bhattacharya-Chatterjee M, Foon KA, Kohler H (1991) Anti-idiotype monoclonal antibodies as vaccines for human cancer. Int Rev Immunol 7: 289
7. Chakraborty M, Foon KA, Kohler H, Bhattacharya-Chatterjee M (1995) Preclinical evaluation in nonhuman primates of an anti-idiotypic antibody that mimicks the carcinoembryonic antigen. J Immunother Emphasis Tumor Immunol 18: 95
8. Chatterjee MB, Foon KA, Kohler H (1994) Idiotypic antibody immunotherapy of cancer. Cancer Immunol Immunother 38: 75
9. Conry RM, LoBuglio AF, Kantor J, Schlom J, Loechel F, Moore SE, Sumerel LA, Barlow DL, Abrams S, Curiel DT (1994) Immune response to a carcinoembryonic antigen polynucleotide vaccine. Cancer Res 54: 1164
10. Conry RM, LoBuglio AF, Loechel F, Moore SE, Sumerel LA, Barlow DL, Curiel DT (1995) A carcinoembryonic antigen polynucleotide vaccine has in vivo antitumor activity. Gene Ther 2: 59
11. Conry RM, LoBuglio AF, Loechel F, Moore SE, Sumerel LA, Barlow DL, Pike J, Curiel DT (1995) A carcinoembryonic antigen polynucleotide vaccine for human clinical use. Cancer Gene Ther 2: 33
12. Conry RM, LoBuglio AF, Wright M, Sumerel L, Pike MJ, Johanning F, Benjamin R, Lu D, Curiel DT (1995) Characterization of a messenger RNA polynucleotide vaccine vector. Cancer Res 55: 1397
13. Conry RM, Saleh MN, Schlom J, LoBuglio AF (1995) Human immune response to carcinoembryonic antigen tumor vaccines. J Immunother 18: 137
14. Conry RM, LoBuglio AF, Curiel DT (1996) Phase 1a trial of a polynucleotide anti-tumor immunization to human carcinoembryonic antigen in patients with metastatic colorectal cancer. Hum Gene Ther 7: 755
15. Conry RM, LoBuglio AF, Curiel DT (1996) Polynucleotide-mediated immunization therapy of cancer. Semin Oncol 23: 135
16. Conry RM, Widera G, LoBuglio AF, Fuller JT, Moore SE, Barlow DL, Turner J, Yang N-S, Curiel DT (1996) Selected strategies to augment polynucleotide immunization. Gene Ther 3: 67
17. Durrant LG, Denton GW, Jacobs E, Mee M, Moss R, Austin EB, Baldwin RW, Hardcastle JD, Robins RA (1992) An idiotypic replica of carcinoembryonic antigen inducing cellular and humoral responses directed against human colorectal tumours. Int J Cancer 50: 811
18. Eidelman FJ, Fuks A, DeMarte L, Taheri M, Stanners CP (1993) Human carcinoembryonic antigen, an intercellular adhesion molecule, blocks fusion and differentiation of rat myoblasts. J Cell Biol 123: 467
19. Fagerberg J, Samanci A, Yi O, Strigard K, Frodin J, Wahren B, Ruden U, Mellstedt H (1995) Recombinant carcinoembryonic antigen and granulocyte-macrophage colony-stimulating factor for active immunization of colorectal carcinoma patients. J Immunother 18: 132
20. Foon KA, Chakraborty M, John WJ, Sherratt A, Kohler H, Bhattacharya-Chatterjee M (1995) Immune response to the carcinoembryonic antigen in patients treated with an anti-idiotype antibody vaccine. J Clin Invest 96: 334
21. Hamilton JM, Chen AP, Nguyen B, Gram J, Abrams S, Chung Y, Kantor J, Phares JC, Bastian A, Brooks C, Morrison G, Allegra CJ, Schlom J (1994) Phase 1 study of recombinant vaccinia virus (rV) that expresses human carcinoembryonic antigen (CEA) in adult patients with adenocarcinomas. Proc Am Assoc Clin Oncol Annu Meet 961
22. Hardman N, Murray B, Zwickl M, Kolbinger F, Pluschke G (1992) Application of genetically-engineered anti-CEA antibodies for potential immunotherapy of colorectal cancer. Int J Biol Markers 7: 203
23. Hodge JW, Abrams S, Schlom J, Kantor JA (1994) Induction of antitumor immunity by recombinant vaccinia viruses expressing B7-1 or B7-2 costimulatory molecules. Cancer Res 54: 5552
24. Hodge JW, McLaughlin JP, Abrams SI, Shupert WL, Schlom J, Kantor JA (1995) Admixture of a recombinant vaccinia virus containing the gene for the costimulatory molecule B7 and a recombinant vaccinia virus containing a tumor-associated antigen gene results in enhanced specific T-cell responses and antitumor immunity. Cancer Res 55: 3598
25. Hodge JW, McLaughlin JP, Kantor JA, Schlom J (1996) Diversified prime and boost protocols using recombinant vaccinia virus and recombinant nonreplicating avian pox virus to enhance T-cell immunity and antitumor responses. Vaccine (in press)
26. Kantor J, Irvine K, Abrams S, Kaufman H, DiPietro J, Schlom J (1992) Antitumor activity and immune responses induced by a recombinant carcinoembryonic antigen-vaccinia virus vaccine. J Natl Cancer Inst 84: 1084
27. Kantor J, Irvine K, Abrams S, Snoy P, Olsen R, Greiner J, Kaufman H, Eggensperger D, Schlom J (1992) Immunogenicity and safety of a recombinant vaccinia virus vaccine expressing the carcinoembryonic antigen gene in a nonhuman primate. Cancer Res 52: 6917
28. Kantor J, Abrams S, Irvine K, Snoy P Kaufman H, Schlom J (1993) Specific immunotherapy using a recombinant vaccinia virus expressing human carcinoembryonic antigen. Ann N Y Acad Sci 690: 370
29. Kaufman H, Schlom J, Kantor J (1991) A recombinant vaccinia virus expressing human carcinoembryonic antigen (CEA). Int J Cancer 48: 900
30. McLaughlin JP, Schlom J, Kantor JA, Greiner JW (1996) Improved immunotherapy of a recombinant carcinoembryonic antigen vaccinia vaccine when given in combination with interleukin-2. Cancer Res 56: 2361
31. Neumaier M, Paululat S, Chan A, Matthaes P, Wagener C (1993) Biliary glycoprotein, a potential human cell adhesion molecule, is down-regulated in colorectal carcinomas. Proc Natl Acad Sci USA 90: 10744
32. Philip R, Brunette E, Philip M, Gadol N, Lyerly HK, Lebkowski JS, Alters S (1995) Generation of tumor specific CTL using genetically modified antigen presenting cells: application in cancer immunotherapy. J Immunother 18: 127
33. Schlom J, Kantor J, Abrams S, Tsang KY, Panicalli D, Hamilton JM (1996) Statagies for the development of recombinant vaccines for the immunotherapy of breast cancer. Breast Cancer Res Treat 38: 27
34. Thompson J, Zimmermann W (1988) The carcinoembryonic antigen gene family: structure, expression and evolution. Tumour Biol 9: 63
35. Thompson JA, Pande H, Paxton RJ, Shively L, Padma A, Simmer RL, Todd CW, Riggs AD, Shively JE (1987) Molecular cloning of a gene belonging to the carcinoembryonic antigen gene family and discussion of a domain model. Proc Natl Acad Sci USA 84: 2965
36. Thompson JA, Grunert F, Zimmermann W (1991) Carcinoembryonic antigen gene family: molecular biology and clinical perspectives. J Clin Lab Anal 5: 344
37. Tsang KY, Zaremba S, Nieroda CA, Zhu MZ, Hamilton JM, Schlom J (1995) Generation of human cytotoxic T cells specific for human carcinoembryonic antigen epitopes from patients immunized with recombinant vaccinia-CEA vaccine. J Natl Cancer Inst 87: 982
38. Zhou H, Fuks A, Alcaraz G, Bolling TJ, Stanners CP (1993) Homophilic adhesion between Ig superfamily carcinoembryonic antigen molecules involves double reciprocal bonds. J Cell Biol 122: 951